Journal
Journal of Allergy and Clinical Immunology
Publication Date
2-1-2023
Volume
151
Issue
2
First Page
547
Last Page
555.e5
Document Type
Open Access Publication
DOI
10.1016/j.jaci.2022.10.021
Rights and Permissions
Dvorak CC, Haddad E, Heimall J, Dunn E, Cowan MJ, Pai SY, Kapoor N, Satter LF, Buckley RH, O'Reilly RJ, Chandra S, Bednarski JJ, Williams O, Rayes A, Moore TB, Ebens CL, Davila Saldana BJ, Petrovic A, Chellapandian D, Cuvelier GDE, Vander Lugt MT, Caywood EH, Chandrakasan S, Eissa H, Goldman FD, Shereck E, Aquino VM, Desantes KB, Madden LM, Miller HK, Yu L, Broglie L, Gillio A, Shah AJ, Knutsen AP, Andolina JP, Joshi AY, Szabolcs P, Kapadia M, Martinez CA, Parrot RE, Sullivan KE, Prockop SE, Abraham RS, Thakar MS, Leiding JW, Kohn DB, Pulsipher MA, Griffith LM, Notarangelo LD, Puck JM. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions. J Allergy Clin Immunol. 2023 Feb;151(2):547-555.e5. doi: 10.1016/j.jaci.2022.10.021. Copyright 2022 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY-NCND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Dvorak, Christopher C; Bednarski, Jeffrey J; and et al., "The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions." Journal of Allergy and Clinical Immunology. 151, 2. 547 - 555.e5. (2023).
https://digitalcommons.wustl.edu/oa_4/2731
Department
ICTS (Institute of Clinical and Translational Sciences)
